Story perspectives

Kennedy Defends Trump's Impossible 600% Drug Cut Claim

4/25/2026

Summary

Story summary

April 22, 2026, Secretary Robert F. Kennedy Jr. defended President Donald Trump’s claim that TrumpRx cuts drug prices by 600 % at a Senate Finance hearing.
Fact-checkers say the 600 % claim is impossible, noting a $600-to-$10 drop equals a 98 % reduction, which Senator Elizabeth Warren called a miscalculation.
Senator Bernie Sanders’ report said policy raised profits by $177 billion in 2025, prompting Senator Ron Wyden’s request for agreements, which Kennedy denied.

History

Historical Context

The 2015 EpiPen scandal, when Mylan lifted the two-pack price from about $100 to $600 – a roughly 500 % jump – triggered congressional hearings and Senator Bernie Sanders’ demand for caps. That public outcry created lasting bipartisan scrutiny of drug pricing, a dynamic now echoed as Robert F. Kennedy Jr. backs President Trump’s claim of a 600 % price cut.

1 of 2

Story summary

April 22, 2026, Secretary Robert F. Kennedy Jr. defended President Donald Trump’s claim that TrumpRx cuts drug prices by 600 % at a Senate Finance hearing.
Fact-checkers say the 600 % claim is impossible, noting a $600-to-$10 drop equals a 98 % reduction, which Senator Elizabeth Warren called a miscalculation.
Senator Bernie Sanders’ report said policy raised profits by $177 billion in 2025, prompting Senator Ron Wyden’s request for agreements, which Kennedy denied.

1 / 2